title: Pharmacologic management of bladder dysfunction in adult women.
abstract: Women commonly experience lower urinary tract symptoms that can severely decrease quality of life. Symptoms are often associated with diagnoses such as urinary incontinence, overactive bladder, and bladder pain syndrome. Expanding evidence supports the effectiveness of many basic nursing interventions, including behavioral management education and optimal use of various pharmacologic agents. The primary focus of this article is pharmacologic treatment of urinary symptoms in women, including new and emerging agents.
authors: Katharine
authors: K
authors: O'Dell
mesh_terms: D000083:Acetanilides / Q000627:therapeutic use; D000279:Administration, Cutaneous; D000284:Administration, Oral; D000328:Adult; D000368:Aged; D001905:Botulinum Toxins / Q000627:therapeutic use*; D018856:Cystitis, Interstitial / Q000175:diagnosis / Q000188:drug therapy; D004967:Estrogens / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008333:Mandelic Acids / Q000627:therapeutic use; D008875:Middle Aged; D011379:Prognosis; D018570:Risk Assessment; D012720:Severity of Illness Index; D013844:Thiazoles / Q000627:therapeutic use; D016896:Treatment Outcome; D001745:Urinary Bladder Diseases / Q000175:diagnosis / Q000188:drug therapy*; D053201:Urinary Bladder, Overactive / Q000175:diagnosis / Q000188:drug therapy; D014549:Urinary Incontinence / Q000175:diagnosis / Q000188:drug therapy; D014550:Urinary Incontinence, Stress / Q000175:diagnosis / Q000188:drug therapy; D014555:Urination Disorders / Q000175:diagnosis / Q000188:drug therapy*; D014563:Urodynamics; D064804:Urological Agents / Q000627:therapeutic use*
chemical_list: D000083:Acetanilides; D004967:Estrogens; D008333:Mandelic Acids; D013844:Thiazoles; D064804:Urological Agents; D001905:Botulinum Toxins; C005419:oxybutynin; C520025:mirabegron
keywords: Urinary incontinence; bladder pain syndrome; overactive bladder; pharmacologic management